Epidemiology, clinical features and diagnosis of Mycobacterium ulcerans in an Australian population

Medical Journal of Australia

Volumn 196, Issue 5, 2012, Pages 341-344

  Boyd, Sarah ^a   Athan, Eugene ^a   Friedman, N Deborah ^a   Hughes, Andrew ^a   Walton, Aaron ^a   Callan, Peter ^a   Mcdonald, Anthony ^a   O'Brien, Daniel ^b  

^a BARWON HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARM DISEASE; ARTICLE; AUSTRALIAN; BACTERIUM CULTURE; BURULI ULCER; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE DURATION; ETHNIC GROUP; FEMALE; GROUPS BY AGE; HUMAN; INCIDENCE; INFECTIOUS ARTHRITIS; LEG DISEASE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PROSPECTIVE STUDY; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BURULI ULCER; CHILD; CHILD, PRESCHOOL; DNA, BACTERIAL; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; MYCOBACTERIUM ULCERANS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; SEX FACTORS; VICTORIA; YOUNG ADULT;

EID: 84859142753     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja12.10087     Document Type: Article

References (28)

1. Pszolla N, Sarkar MR, Strecker W, et al. Buruli ulcer: a systemic disease. Clin Infect Dis 2003; 37: e78-e82.
2. Sizaire V, Nackers F, Comte E, Portaels F. Mycobacterium ulcerans infection: control, diagnosis, and treatment. Lancet Infect Dis 2006; 6: 288-296.
3. Lavender CJ, Fyfe JA, Azuolas J, et al. Risk of Buruli ulcer and detection of Mycobacterium ulcerans in mosquitoes in southeastern Australia. PLoS Negl Trop Dis 2011; 5: e1305.
4. Veitch MGK, Johnson PDR, Flood PE, et al. A large localized outbreak of Mycobacterium ulcerans infection on a temperate southern Australian island. Epidemiol Infect 1997; 119: 313-318.
5. Marsollier L, Deniaux E, Brodin P, et al. Protection against Mycobacterium ulcerans lesion development by exposure to aquatic insect saliva. PLoS Med 2007; 4: e64.
6. Johnson PDR, Stinear T, Small PLC, et al. Buruli ulcer (M. ulcerans infection): new insights, new hope for disease control. PLoS Med 2005; 2: e108.
7. Quek TYJ, Athan E, Henry MJ, et al. Risk factors for Mycobacterium ulcerans infection, southeastern Australia. Emerg Infect Dis 2007; 13: 1661-1666.
8. Fyfe JAM, Lavender CJ, Handasyde KA, et al. A major role for mammals in the ecology of Mycobacterium ulcerans. PLoS Negl Trop Dis 2010; 4: e791.
9. Raghunathan PL, Whitney EA, Asamoa K, et al. Risk factors for Buruli ulcer disease (Mycobacterium ulcerans infection): results from a case-control study in Ghana. Clin Infect Dis 2005; 40: 1445-1453.
10. van der Werf TS, van der Graaf WTA, Tappero JW, Asiedu K. Mycobacterium ulcerans infection. Lancet 1999; 354: 1013-1018.
11. Debacker M, Aguiar J, Steunou C, et al. Mycobacterium ulcerans disease (Buruli ulcer) in rural hospital, Southern Benin, 1997-2001. Emerg Infect Dis 2004; 10: 1391-1398.
12. Debacker M, Portaels F, Aguiar J, et al. Risk factors for Buruli ulcer, Benin. Emerg Infect Dis 2006; 12: 1325-1331.
13. Guarner J, Bartlett J, Whitney EAS, et al. Histopathologic features of Mycobacterium ulcerans infection. Emerg Infect Dis 2003; 9: 651-656.
14. Wansbrough-Jones M, Phillips R. Buruli ulcer: emerging from obscurity. Lancet 2006; 367: 1849-1858.
15. World Health Organization. Buruli ulcer: progress report 2004-2008. Wkly Epidemiol Rec 2008; 83: 145-156.
16. Debacker M, Aguiar J, Steunou C, et al. Mycobacterium ulcerans disease: role of age and gender in incidence and morbidity. Trop Med Int Health 2004; 9: 1297-1304.
17. Sopoh GE, Johnson RC, Chauty A, et al. Buruli ulcer surveillance, Benin 2003-2005. Emerg Infect Dis 2007; 13: 1374-1376.
18. Lavender CJ, Senanayake SN, Fyfe JAM, et al. First case of Mycobacterium ulcerans disease (Bairnsdale or Buruli ulcer) acquired in New South Wales. Med J Aust 2007; 186: 62-63.
19. Stienstra Y, van der Graaf WTA, Asamoa K, van der Werf TS. Beliefs and attitudes towards Buruli ulcer in Ghana. Am J Trop Med Hyg 2002; 67: 207-213.
20. Quek TYJ, Henry MJ, Pasco JA, et al. Mycobacterium ulcerans infection: factors influencing diagnostic delay. Med J Aust 2007; 187: 561-563.
21. Drummond C, Butler JR. Mycobacterium ulcerans treatment costs, Australia. Emerg Infect Dis 2004; 10: 1038-1043.
22. Pak J, O'Brien DP, Quek T, Athan E. Treatment costs of Mycobacterium ulcerans in the antibiotic era. Int Health Epub 2012 Feb 16. doi: 10.1016/ j.inhe.2011.12.005.
23. Amofah F, Bonsu F, Tetteh C, et al. Buruli ulcer in Ghana: results of a national case search. Emerg Infect Dis 2002; 8: 167-170.
24. Mve-Obiang A, Lee RE, Portaels F, Small PL. Heterogeneity of mycolactones produced by clinical isolates of Mycobacterium ulcerans: implications for virulence. Infect Immun 2003; 71: 774-783.
25. Johnson PDR, Hayman JA, Quek TY, et al; Mycobacterium ulcerans Study Team. Consensus recommendations for the diagnosis, treatment and control of Mycobacterium ulcerans infection (Bairnsdale or Buruli ulcer) in Victoria, Australia. Med J Aust 2007; 186: 64-68.
26. Phillips R, Horsfield C, Kuijper S, et al. Sensitivity of PCR targeting the IS2404 insertion sequence of Mycobacterium ulcerans in an assay using punch biopsy specimens for diagnosis of Buruli ulcer. J Clin Microbiol 2005; 43: 3650-3656.
27. O'Brien DP, McDonald A, Callan P, et al. Successful outcomes with oral fluoroquinolones combined with rifampicin in the treatment of Mycobacterium ulcerans: an observational cohort study. PLoS Negl Trop Dis 2012; 6: e1473.
28. O'Brien DP, Robson ME, Callan PP, McDonald AH. "Paradoxical" immune-mediated reactions to Mycobacterium ulcerans during antibiotic treatment: a result of treatment success, not failure. Med J Aust 2009; 191: 564-566.